Innovator support is provided by all AHSNs – the Innovation Pathway sets out the range of services offered.
The Oxford AHSN is working with industry and its NHS partners to create the conditions and opportunities for companies to grow and access the home market for revenue generation. Our partners are already developing innovative models of care, effectively creating a ‘lit runway’ for innovations to follow.
Key considerations when commercialising a product for the NHS are:
- How will the product or service change clinical practice?
- Will the innovation enable a new model of care?
- What is the clinical, economic and social impact of the technology?
- How will these impacts be measured?
- Is a redesign required in healthcare pathways to take full advantage of these impacts?
- How will the redesign be funded?
- What are the dissemination routes?
These questions originated from the Accelerated Access Review and we have developed this interactive guide to help you on you along the innovation pathway. We offer support throughout the process, including signposting to local partners and services and guidance on navigating the local ecosystem.
In 2019 the Oxford AHSN launched an Accelerator programme in collaboration with BioCity. Details here.
Joint working agreements
The Oxford AHSN has a strategic partnership with the global healthcare company Johnson & Johnson (J&J). A joint Memorandum of Understanding has been signed to formalise a strategic partnership recognising the synergies between them relating to improving patient care and health outcomes and accelerating access to new innovations and technologies through academic and commercial collaborations.
Through this unique partnership, we are exploring further opportunities to share knowledge and expertise, in order to help develop innovative local health services and advance the health of people across the region.
The Oxford AHSN is working with companies and innovators to provide opportunities to grow and access the home market for revenue generation. See examples below:
Long term health conditions
- 2020 Accelerator programme
- TrueColours IBD
- Oxford AHSN Accelerator winners
- Sensyne Health
- Owen Mumford